Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.

BMC Cancer · 2020 · PMC7425050 · PMID 32787805

Europe PMC DOI

hedged sentences

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendp = 0.079so close (0.05 < p ≤ 0.1)

In our previous study we showed a trend for improved OS for average risk patients treated with chemotherapy after a median follow up of 10 years ( p = 0.079) [ 15 ] .

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Relapse-free survival and overall survival did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.